aspirin and Coronary Stenosis studies

Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.

Research Excerpts

Excerpt	Relevance	Reference
"In vasospastic angina without significant coronary artery stenosis, patients taking low-dose aspirin are at higher risk of MACE, driven primarily by tendency toward rehospitalization."	7.83	Clinical implications of low-dose aspirin on vasospastic angina patients without significant coronary artery stenosis; a propensity score-matched analysis. ( Ahn, J; Carriere, KC; Cho, SW; Choi, JH; Choi, SH; Gwag, HB; Gwon, HC; Hahn, JY; Lee, da H; Lee, SH; Lim, AY; Oh, MS; Park, TK; Seong, CS; Song, YB; Yang, JH, 2016)
"We sought to examine the risk of mortality associated with nonobstructive coronary artery disease (CAD) and to determine the impact of baseline statin and aspirin use on mortality."	7.81	Prognostic and therapeutic implications of statin and aspirin therapy in individuals with nonobstructive coronary artery disease: results from the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter registry) re ( Achenbach, S; Al-Mallah, M; Berman, DS; Budoff, MJ; Cademartiri, F; Callister, TQ; Chang, HJ; Chen, L; Cheng, VY; Chinnaiyan, K; Chow, BJ; Cury, R; Delago, A; Dunning, A; Feuchtner, G; Hadamitzky, M; Hausleiter, J; Karlsberg, RP; Kaufmann, PA; Kim, YJ; LaBounty, T; Leipsic, J; Lin, F; Maffei, E; McPherson, R; Min, JK; Raff, GL; Shaw, LJ; Small, G; Villines, TC; Yam, Y, 2015)
"The effects of dual antiplatelet therapy with aspirin and clopidogrel on the progression of native coronary artery disease after coronary artery bypass grafting are unknown."	7.80	Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial. ( Al-Atassi, T; Kulik, A; Le May, M; Ruel, M; Une, D; Voisine, P, 2014)
"After the end of the ESCAPE study with patients with type 2 diabetes mellitus (T2DM) and mild to moderate coronary artery stenosis, we decided to extend the ESCAPE study to investigate the long-term effect of cilostazol and aspirin, named the ESCAPE-extension study."	5.51	Cilostazol treatment for preventing adverse cardiovascular events in patients with type 2 diabetes and coronary atherosclerosis: Long-term follow-up of the ESCAPE study. ( Chun, EJ; Lim, S; Sohn, M, 2022)
"Tirofiban was administered for 24 h and the IABP was withdrawn after 60 h."	5.35	Reversible clopidogrel resistance due to right ventricular myocardial infarction: risk factor of recurrent stent thrombosis? ( Braun-Dullaeus, RC; Hass, N; Ibrahim, K; Kolschmann, S; Strasser, RH, 2008)
"8 years with 10-75% coronary artery stenosis, as assessed by coronary computed tomography angiography, were randomly assigned to sarpogrelate 300 mg/day plus aspirin 100 mg/day (SPG + ASA group) or aspirin 100 mg/day alone (ASA group) for 6 months."	5.24	Effect of sarpogrelate, a selective 5-HT ( Chun, EJ; Han, SJ; Hur, JH; Jang, HC; Kang, DK; Kim, HJ; Kim, KM; Lee, DH; Lee, JE; Lim, S; Min, SH; Oh, TJ, 2017)
"Eighty-two consecutive patients with stable angina pectoris who received Resolute zotarolimus-eluting stents (R-ZESs; Medtronic Cardiovascular, Santa Rosa, CA, USA) were enrolled."	3.88	Comparison of the 9-month intra-stent conditions and 2-year clinical outcomes after Resolute zotarolimus-eluting stent implantation between 3-month and standard dual antiplatelet therapy. ( Fujimoto, W; Kawai, H; Miyata, T; Oishi, S; Onishi, T; Osue, T; Sawada, T; Shimane, A; Takahashi, Y; Takaya, T; Taniguchi, Y; Toba, T; Yasaka, Y, 2018)
"Cilostazol was associated with a significant reduction in late loss in BMS (mean difference 0."	3.84	Efficacy of cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials. ( Chen, KY; Chetcuti, S; Grossman, MP; Gurm, H; Meier, P; Rha, SW; Tamhane, U, 2009)
"In vasospastic angina without significant coronary artery stenosis, patients taking low-dose aspirin are at higher risk of MACE, driven primarily by tendency toward rehospitalization."	3.83	Clinical implications of low-dose aspirin on vasospastic angina patients without significant coronary artery stenosis; a propensity score-matched analysis. ( Ahn, J; Carriere, KC; Cho, SW; Choi, JH; Choi, SH; Gwag, HB; Gwon, HC; Hahn, JY; Lee, da H; Lee, SH; Lim, AY; Oh, MS; Park, TK; Seong, CS; Song, YB; Yang, JH, 2016)
"We sought to examine the risk of mortality associated with nonobstructive coronary artery disease (CAD) and to determine the impact of baseline statin and aspirin use on mortality."	3.81	Prognostic and therapeutic implications of statin and aspirin therapy in individuals with nonobstructive coronary artery disease: results from the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter registry) re ( Achenbach, S; Al-Mallah, M; Berman, DS; Budoff, MJ; Cademartiri, F; Callister, TQ; Chang, HJ; Chen, L; Cheng, VY; Chinnaiyan, K; Chow, BJ; Cury, R; Delago, A; Dunning, A; Feuchtner, G; Hadamitzky, M; Hausleiter, J; Karlsberg, RP; Kaufmann, PA; Kim, YJ; LaBounty, T; Leipsic, J; Lin, F; Maffei, E; McPherson, R; Min, JK; Raff, GL; Shaw, LJ; Small, G; Villines, TC; Yam, Y, 2015)
" We present the case of a 50-year-old male with the Samter-Beer triad of asthma, nasal polyps, and salicylate intolerance with an ST elevation myocardial infarction complicated with cardiac arrest due to multi-vessel coronary artery spasm secondary to aspirin anaphylaxis."	3.81	Kounis syndrome with Samter-Beer triad treated with intracoronary adrenaline. ( Ihdayhid, AR; Rankin, J, 2015)
" Meta-analyses evaluated effectiveness and adverse side effects for one-month administrations of aspirin plus cilostazol or aspirin plus ticlopidine therapy after coronary stenting."	3.81	Comparison of cilostazol and ticlopidine for one-month effectiveness and safety after elective coronary stenting. ( Hashiguchi, M; Kishino, S; Mochizuki, M; Nakazawa, R; Ohno, K; Shiga, T, 2004)
"The effects of dual antiplatelet therapy with aspirin and clopidogrel on the progression of native coronary artery disease after coronary artery bypass grafting are unknown."	3.80	Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial. ( Al-Atassi, T; Kulik, A; Le May, M; Ruel, M; Une, D; Voisine, P, 2014)
"We report a 56-year-old patient who had been taking antihypertensive medication in combination with prophylactic aspirin for 19 years who was diagnosed with stable angina with significant coronary artery stenosis on angiography."	3.75	Spontaneous spinal epidural hematoma: an urgent complication of adding clopidogrel to aspirin therapy. ( Chung, HS; Kim, JH; Kwon, TH; Moon, HJ; Park, YK, 2009)
"5% in the ticlopidine group, and myocardial infarction (MI) was also reduced in the clopidogrel group (4."	3.72	Clopidogrel is associated with better in-hospital and 30-day outcomes than ticlopidine after coronary stenting. ( Albirini, A; Aronow, HD; Bhatt, DL; Cura, FA; Ellis, SG; L'Allier, PL; Schneider, JP; Topol, EJ, 2003)
"Even very short-term dual antiplatelet therapy seems safe after coronary stenting with Genous in de novo coronary artery lesions located in secondary branch vessels."	2.76	Evaluating the safety of very short-term (10 days) dual antiplatelet therapy after Genous™ bio-engineered R stent™ implantation: the multicentre pilot Genous trial. ( Biondi-Zoccai, G; Bramucci, E; Colombo, A; Ferlini, M; Grinfeld, L; Iadanza, A; Morice, MC; Petronio, AS; Pierli, C; Sangiorgi, GM, 2011)
"Aspirin efficacy was assessed by using arachidonic acid-induced platelet aggregation."	2.73	Platelet activity and aspirin efficacy after off-pump compared with on-pump coronary artery bypass surgery: results from the prospective randomized trial PRAGUE 11-Coronary Artery Bypass and REactivity of Thrombocytes (CABARET). ( Bednar, F; Jares, M; Mocikova, H; Osmancik, P; Straka, Z; Vanek, T; Widimsky, P, 2008)
" Major adverse cardiac events (death, myocardial infarction, target lesion revascularization, and coronary artery bypass grafting) were observed at 30 days in 5 of 200 (2."	2.71	Safety of an aspirin-alone regimen after intracoronary stenting with a heparin-coated stent: final results of the HOPE (HEPACOAT and an Antithrombotic Regimen of Aspirin Alone) study. ( Ashby, DT; Aymong, ED; Fischell, T; Lansky, AJ; Leon, MB; Mehran, R; Narasimaiah, R; Siegel, R; Thomas, W; Whitworth, H; Wong, SC, 2003)
"The etiology of Kawasaki disease (KD) remains unknown despite several years of dedicated research in this direction."	2.43	Current perspectives on Kawasaki disease. ( Gupta-Malhotra, M; Rao, PS, 2005)
"Chronic myocardial ischemia was induced using a minimally invasive model in 16 landrace pigs."	1.37	Gene therapy with iNOS enhances regional contractility and reduces delayed contrast enhancement in a model of postischemic congestive heart failure. ( Abegunewardene, N; Gori, T; Horstick, G; Kreitner, KF; Lehr, HA; Münzel, T; Schmidt, KH; Schreiber, LM; Vosseler, M, 2011)
"Tirofiban was administered for 24 h and the IABP was withdrawn after 60 h."	1.35	Reversible clopidogrel resistance due to right ventricular myocardial infarction: risk factor of recurrent stent thrombosis? ( Braun-Dullaeus, RC; Hass, N; Ibrahim, K; Kolschmann, S; Strasser, RH, 2008)
"Isolated splenic infarction as a complication of the procedure is extreme rare."	1.35	Athero-embolic isolated splenic infarction following left cardiac catheterization. ( Hussein, A; Irani, F; Kasmani, R; Mohan, G, 2009)
" We assessed the cumulative incidence of major adverse cardiac events (death, acute myocardial infarction, and target-vessel revascularization) and angiographic stent thrombosis during 2-year follow-up."	1.34	Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry. ( Aurier, E; Benassi, A; Cremonesi, A; Grilli, R; Guastaroba, P; Magnavacchi, P; Manari, A; Maresta, A; Marzocchi, A; Percoco, G; Piovaccari, G; Saia, F; Varani, E, 2007)
"Congenital factor V deficiency is an uncommon bleeding disorder that necessitates hemostatic correction before surgery."	1.33	Off-pump coronary artery bypass grafting in a patient with congenital factor V deficiency: report of a case. ( Iguro, Y; Kinjo, T; Masuda, H; Sakata, R; Toyokawa, K; Yotsumoto, G, 2005)
" An independent endpoint review committee adjudicated all reported major adverse cardiovascular events, stent thromboses, and target-vessel revascularizations."	1.33	Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry. ( Berge, C; Deme, M; Gershlick, AH; Guagliumi, G; Guyon, P; Lotan, C; Schofer, J; Seth, A; Sousa, JE; Stoll, HP; Urban, P; Wijns, W, 2006)
"Pretreatment with parecoxib (20 mg/kg) almost doubled shear stress-induced platelet aggregation (188% vs."	1.33	Cyclooxygenase-2 inhibitors enhance shear stress-induced platelet aggregation. ( Borgdorff, P; Paulus, WJ; Tangelder, GJ, 2006)
"Patients with complex coronary stenoses had a significantly (P<0."	1.32	Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. ( Christiansen, M; Cole, D; Cosin-Sales, J; Holt, DW; Kaminski, P; Kaski, JC; Overgaard, MT; Oxvig, C, 2004)
"Previous myocardial infarction was found in 70 patients (28%)."	1.32	National survey of coronary artery bypass grafting for coronary stenosis caused by Kawasaki disease in Japan. ( Kitamura, S; Tsuda, E, 2004)

Research

Studies (126)

Authors

Clinical Trials (38)

Trial Overview

Trial Outcomes

Number of Participants With a Bleeding Academic Research Consortium (BARC) 3 or 5 Bleeding

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (0.79)	18.2507
2000's	73 (57.94)	29.6817
2010's	46 (36.51)	24.3611
2020's	6 (4.76)	2.80

Authors	Studies
Sohn, M	1
Chun, EJ	2
Lim, S	2
Hwang, IC	1
Lee, H	3
Yoon, YE	1
Choi, IS	1
Kim, HL	1
Chang, HJ	2
Lee, JY	1
Choi, JA	1
Kim, HJ	2
Cho, GY	1
Park, JB	1
Lee, SP	2
Kim, HK	2
Kim, YJ	2
Sohn, DW	1
Ehelepola, NDB	1
Athurupana, AASD	1
Bowatte, PGCS	1
Dissanayake, WP	1
Yang, H	1
Zhang, F	1
Yang, J	1
Zheng, M	1
Cao, R	1
Dai, Y	1
Li, C	1
Yao, K	1
Qian, J	1
Ge, J	1
Bocchino, PP	1
De Filippo, O	1
Piroli, F	1
Scacciatella, P	1
Imazio, M	1
D'Ascenzo, F	1
De Ferrari, GM	1
Kawashima, H	1
Tomaniak, M	1
Ono, M	1
Wang, R	1
Hara, H	1
Gao, C	2
Takahashi, K	1
Sharif, F	1
Thury, A	1
Suryapranata, H	1
Walsh, S	1
Cotton, J	1
Carrie, D	1
Sabate, M	4
Steinwender, C	1
Leibundgut, G	1
Wykrzykowska, J	1
de Winter, RJ	1
Garg, S	1
Hamm, C	1
Steg, PG	1
Jüni, P	2
Vranckx, P	1
Valgimigli, M	2
Windecker, S	1
Onuma, Y	1
Serruys, PW	1
Kitano, D	1
Migita, S	1
Li, Y	1
Takahashi, R	1
Taniguchi, Y	2
Kurosawa, T	1
Sudo, M	1
Haruta, H	1
Hiro, T	1
Takayama, T	1
Mitsumata, M	1
Matsumoto, T	1
Okumura, Y	1
Hirayama, A	1
Kim, BS	2
Chan, N	1
Hsu, G	1
Makaryus, AN	1
Chopra, M	1
Cohen, SL	1
Makaryus, JN	1
Mori, M	1
Sakata, K	2
Nakanishi, C	1
Nakahashi, T	1
Kawashiri, MA	1
Yoshioka, K	1
Takuwa, Y	1
Okada, H	1
Yokawa, JI	1
Shimojima, M	1
Yoshimuta, T	1
Yoshida, S	1
Yamagishi, M	1
Hayashi, K	1
Lee, KY	1
Hwang, BH	1
Kim, TH	1
Kim, CJ	1
Kim, JJ	3
Choo, EH	1
Choi, IJ	1
Choi, Y	1
Park, HW	1
Koh, YS	1
Kim, PJ	1
Lee, JM	1
Kim, MJ	1
Jeon, DS	1
Cho, JH	1
Jung, JI	1
Seung, KB	1
Chang, K	1
Joo, HJ	1
Park, JY	1
Hong, SJ	1
Kim, KA	1
Lee, SH	3
Cho, JY	1
Park, JH	1
Yu, CW	1
Lim, DS	2
Chang, AM	1
Litt, HI	1
Snyder, BS	1
Gatsonis, C	1
Greco, EM	1
Miller, CD	1
Singh, H	1
O'Conor, KJ	1
Hollander, JE	1
Fujimoto, W	1
Sawada, T	1
Toba, T	1
Takahashi, Y	1
Miyata, T	1
Oishi, S	1
Osue, T	1
Onishi, T	1
Takaya, T	1
Shimane, A	1
Kawai, H	1
Yasaka, Y	1
Parodi, G	1
Nusdeo, G	1
Terrosu, P	1
Kitano, T	1
Matsubara, S	1
Uno, M	1
Yagita, Y	1
Verdoia, M	1
Nardin, M	1
Negro, F	1
Rolla, R	1
Carriero, A	1
De Luca, G	1
Stone, GW	2
Witzenbichler, B	2
Weisz, G	1
Rinaldi, MJ	1
Neumann, FJ	1
Metzger, DC	1
Henry, TD	1
Cox, DA	1
Duffy, PL	1
Mazzaferri, E	1
Gurbel, PA	2
Xu, K	1
Parise, H	1
Kirtane, AJ	1
Brodie, BR	1
Mehran, R	3
Stuckey, TD	1
Ho, HH	2
Er Ching, M	1
Ong, PJ	2
Ooi, YW	2
Fukuyama, K	1
Fujikawa, T	1
Kuramitsu, S	1
Tanaka, A	2
López Mínguez, JR	1
Nogales Asensio, JM	1
Doncel Vecino, LJ	1
Sandoval, J	1
Romany, S	1
Martínez Romero, P	1
Fernández Díaz, JA	1
Fernández Portales, J	1
González Fernández, R	1
Martínez Cáceres, G	1
Merchán Herrera, A	1
Alfonso Manterola, F	1
Une, D	1
Al-Atassi, T	1
Kulik, A	1
Voisine, P	1
Le May, M	1
Ruel, M	1
Chow, BJ	1
Small, G	1
Yam, Y	1
Chen, L	1
McPherson, R	1
Achenbach, S	1
Al-Mallah, M	1
Berman, DS	1
Budoff, MJ	1
Cademartiri, F	1
Callister, TQ	1
Cheng, VY	1
Chinnaiyan, K	1
Cury, R	1
Delago, A	1
Dunning, A	1
Feuchtner, G	1
Hadamitzky, M	2
Hausleiter, J	1
Karlsberg, RP	1
Kaufmann, PA	1
Leipsic, J	1
LaBounty, T	1
Lin, F	1
Maffei, E	1
Raff, GL	1
Shaw, LJ	1
Villines, TC	1
Min, JK	2
Harris, K	1
Kebbe, J	1
Nishimiya, K	1
Matsumoto, Y	1
Uzuka, H	1
Oyama, K	1
Taruya, A	1
Ogata, T	1
Hirano, M	1
Shindo, T	1
Hanawa, K	1
Hasebe, Y	1
Hao, K	1
Tsuburaya, R	1
Takahashi, J	1
Miyata, S	1
Ito, K	1
Akasaka, T	1
Shimokawa, H	1
Yang, M	1
Bai, X	1
Xu, J	1
Ni, J	1
Tang, J	1
Zeng, Y	1
Fang, Q	1
Shi, H	1
Lee, CH	1
Chan, MY	1
Low, AF	1
Teo, SG	1
Chan, KH	1
Sethi, R	1
Richards, AM	1
Tan, HC	1
Ihdayhid, AR	1
Rankin, J	1
De Servi, S	1
Morici, N	1
Boschetti, E	1
Rossini, R	1
Martina, P	1
Musumeci, G	1
D'Urbano, M	1
Lazzari, L	1
La Vecchia, C	1
Senni, M	1
Klugmann, S	1
Savonitto, S	1
Lim, AY	1
Park, TK	1
Cho, SW	1
Oh, MS	1
Lee, da H	1
Seong, CS	1
Gwag, HB	1
Yang, JH	1
Song, YB	2
Hahn, JY	2
Choi, JH	2
Gwon, HC	2
Ahn, J	1
Carriere, KC	1
Choi, SH	2
Cho, MH	1
Shin, DW	1
Yun, JM	1
Shin, JH	1
Lim, YK	1
Kim, EH	1
Lee, DH	1
Hur, JH	1
Min, SH	1
Lee, JE	1
Oh, TJ	1
Kim, KM	1
Jang, HC	1
Han, SJ	1
Kang, DK	1
Koo, BK	1
Park, KW	1
Shin, ES	1
Lim, SW	1
Rha, SW	3
Bae, JW	1
Jeon, DW	1
Oh, SK	1
Hur, SH	2
Lee, JH	1
Park, TH	1
Lee, NH	1
Kim, HS	2
Ibrahim, K	1
Hass, N	1
Kolschmann, S	1
Strasser, RH	1
Braun-Dullaeus, RC	1
Bednar, F	1
Osmancik, P	1
Vanek, T	1
Mocikova, H	1
Jares, M	1
Straka, Z	1
Widimsky, P	1
Hemetsberger, R	1
Farhan, S	1
Strehblow, C	1
Sperker, W	1
Pavo, I	1
Petrasi, Z	1
Hemetsberger, H	1
Posa, A	1
Huber, K	2
Glogar, D	1
Gyöngyösi, M	1
Jang, SW	1
Kim, DB	1
Kwon, BJ	1
Shin, D	1
Her, SH	1
Park, CS	1
Park, HJ	1
Park, MW	1
Cho, EJ	1
Rho, TH	1
Kim, JH	3
Bevilacqua, S	1
Alkodami, AA	1
Volpi, E	1
Cerillo, AG	1
Berti, S	1
Glauber, M	1
Gianetti, J	1
Lim, E	1
Hussein, A	1
Kasmani, R	1
Irani, F	1
Mohan, G	1
Cola, C	1
Brugaletta, S	1
Martín Yuste, V	1
Campos, B	1
Angiolillo, DJ	4
Ren, C	1
Li, D	1
Li, L	1
Moon, HJ	1
Kwon, TH	1
Chung, HS	1
Park, YK	1
Tamhane, U	1
Meier, P	1
Chetcuti, S	1
Chen, KY	1
Grossman, MP	1
Gurm, H	1
LaBounty, TM	1
Devereux, RB	1
Lin, FY	1
Weinsaft, JW	1
Obradović, S	1
Subota, V	1
Baskot, B	1
Dopudja, M	1
Antonijević, N	1
Djenić, N	1
Vukotić, S	1
Salinger, S	1
Jovelić, A	1
Miković, D	1
Antović, J	1
Grdenić, A	1
Gligić, B	1
Gupta, N	1
Nayak, R	1
Grisolano, SW	1
Buckles, DC	1
Tadros, PN	1
Yong, AS	1
Pennings, GJ	1
Chang, M	1
Hamzah, A	1
Chung, T	1
Qi, M	1
Brieger, D	2
Behnia, M	1
Krilis, SA	1
Ng, MK	1
Lowe, HC	3
Kritharides, L	1
Lee, SY	1
Park, HS	1
Lee, S	1
Han, KR	1
Cho, BR	1
Park, JS	1
Yoon, J	1
Kozuma, K	1
Ota, Y	1
Nagai, Y	1
Katsuta, Y	1
Nozaki, E	1
Onodera, T	1
Ikari, Y	1
Kotani, J	1
Kyo, E	1
Yokoi, H	1
Nakamura, M	1
Egred, M	1
Tchan, M	1
Sillence, D	1
Niccoli, G	1
Minelli, S	1
Cosentino, N	1
Crea, F	1
Douglas, PS	1
Patel, MR	1
Bailey, SR	1
Dai, D	1
Kaltenbach, L	1
Brindis, RG	1
Messenger, J	1
Peterson, ED	1
Stankovic, I	1
Vlahovic-Stipac, A	1
Ilic, I	1
Putnikovic, B	1
Neskovic, AN	1
Sangiorgi, GM	1
Morice, MC	2
Bramucci, E	1
Ferlini, M	1
Grinfeld, L	1
Petronio, AS	1
Pierli, C	1
Iadanza, A	1
Biondi-Zoccai, G	1
Colombo, A	2
Abegunewardene, N	1
Schmidt, KH	1
Vosseler, M	1
Kreitner, KF	1
Schreiber, LM	1
Lehr, HA	1
Gori, T	1
Münzel, T	1
Horstick, G	1
Tzeng, SS	1
Liou, JT	1
Canpolat, U	1
Yorgun, H	1
Atalar, E	1
Linares Vicente, JA	1
Pérez, JO	1
Lacasa, RC	1
De Bruyne, B	1
Pijls, NH	1
Kalesan, B	1
Barbato, E	1
Tonino, PA	1
Piroth, Z	1
Jagic, N	1
Möbius-Winkler, S	1
Mobius-Winckler, S	1
Rioufol, G	1
Witt, N	1

Trial	Phase	Enrollment	Study Type	Start Date	Status
A Prospective Multi-center Open-label Controlled Trial of Comparison 3 vs 12 Months of Dual Anti-Platelet Therapy After Implantation of Firehawk Sirolimus Target- Eluting Stent in Patients With Stable Coronary Artery Disease[NCT03008083]	Phase 4	2,446 participants (Anticipated)	Interventional	2019-01-10	Recruiting
GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation[NCT01813435]	Phase 3	15,991 participants (Actual)	Interventional	2013-07-01	Completed
A Randomized, Open-label, Active-controlled, Parallel-group Study to Investigate the Platelet Inhibition of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease and Type 2 Diabetes Mellitus After Recent Elective Percutaneous Coron[NCT02748330]	Phase 4	40 participants (Actual)	Interventional	2016-06-30	Completed
A Single-center, Randomized, Open-label, Controlled, Dose-escalating, Parallel-group Study to Assess the Anti-platelet Effect of Berberine in Patients Receiving Aspirin and Clopidogrel After Percutaneous Coronary Intervention[NCT03378934]	Phase 4	64 participants (Anticipated)	Interventional	2018-09-26	Recruiting
Effect of Low Dose of Colchicine on Platelet Reactivty in Patients With Chronic Coronary Disease[NCT05956145]	Phase 3	80 participants (Anticipated)	Interventional	2021-06-17	Recruiting
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents[NCT00638794]		8,575 participants (Actual)	Observational	2008-01-31	Completed
Comparison of Antiplatelet Therapy With Clopidogrel and Ticagrelor in Patients After Cardiac Arrest Treated With Therapeutic Hypothermia[NCT02224274]	Phase 4	57 participants (Actual)	Interventional	2014-08-31	Completed
Impact of Preoperative FFR on Arterial Bypass Graft Functionality: Towards a New CABG Paradigm[NCT02527044]		120 participants (Anticipated)	Interventional	2015-11-30	Active, not recruiting
Clopidogrel After Surgery for Coronary Artery Disease (CASCADE Trial): Does Clopidogrel Prevent Saphenous Vein Graft Disease After Coronary Bypass?[NCT00228423]	Phase 2	113 participants (Actual)	Interventional	2006-05-31	Completed
COronary CT Angiography Evaluation For Clinical Outcomes: An International Multicenter Registry[NCT01443637]		34,000 participants (Actual)	Observational	2003-06-30	Completed
Optimal Strategy for Side Branch Stenting in Coronary Bifurcation Lesion[NCT00794014]		258 participants (Actual)	Interventional	2007-11-30	Completed
A Prospective, Multicenter, Blinded, Randomized, Noninferiority Clinical Trial of Coronary Angiography Fractional Flow Reserve (caFFR) Versus Fractional Flow Reserve (FFR) to Guide Percutaneous Coronary Intervention（Flash FFR Ⅱ ）[NCT04575207]		2,132 participants (Anticipated)	Interventional	2021-01-12	Recruiting
The Impact of Coronary Revascularization on Absolute Myocardial Blood Flow as Assessed by Stress Myocardial Positron Tomography[NCT02931331]		50 participants (Anticipated)	Observational [Patient Registry]	2016-03-31	Enrolling by invitation
FLOW 3 - The Association Between Catheter-based Absolute Coronary Flow and Resistance and 15O-H2O Positron Emission Tomography Scan-based Absolute Myocardial Blood Flow in the Coronary Artery Territory.[NCT04973410]		40 participants (Anticipated)	Interventional	2019-12-01	Recruiting
Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI (REFINE PCI)[NCT05491668]		107 participants (Anticipated)	Observational	2022-10-11	Recruiting
Fractional Flow Reserve-Guided Percutaneous Coronary Intervention Plus Optimal Medical Treatment Versus Optimal Medical Treatment Alone in Patients With Stable Coronary Artery Disease[NCT01132495]		1,170 participants (Actual)	Interventional	2010-05-31	Completed
A Randomised Controlled Trial to Compare Routine Pressure Wire Assessment With Conventional Angiography in the Management of Patients With Coronary Artery Disease.[NCT02892903]		1,100 participants (Actual)	Interventional	2016-09-30	Active, not recruiting
RELATionship bEtween Lesion-level Invasive Fractional Flow Reserve AND Endothelial Wall Shear Stress the RELATE FFR and WSS Study[NCT04048005]		200 participants (Anticipated)	Observational	2017-01-01	Recruiting
Comparison of Quantitative Flow Ratio Guided and Angiography Guided Percutaneous InterVention in Patients With cORonary Artery Disease (The FAVOR III China Study)[NCT03656848]		3,847 participants (Actual)	Interventional	2018-12-25	Active, not recruiting
Assessment of NOn-culprit Lesions With dobutamiNe Stress eChocardiography, compUted Tomography and Fractional fLow Reserve in Patients With Acute[NCT03988881]		100 participants (Anticipated)	Observational	2017-03-30	Recruiting
Revascularization With Paclitaxel-coated Balloon Angioplasty Versus Drug-eluting Stenting in Acute Myocardial Infarction - a Randomized Controlled Trial.[NCT02219802]		120 participants (Anticipated)	Interventional	2014-08-31	Not yet recruiting
Prognostic Impact of Fractional Flow Reserve in Chronic Coronary Syndrome: Quasi-Experimental Findings Using a Regression Discontinuity Design[NCT05592535]		5,000 participants (Actual)	Observational	2015-06-01	Completed
Evaluation of Diagnostic Accuracy, Safety, and Cost-Effectiveness of the Non-Invasive Cardiolens FFR-CT Pro Method to Measure the Fractional Flow Reserve in Diagnostics of Chronic Coronary Syndromes Versus the Standard Diagnostic Modalities. A Multicentre[NCT04777513]		450 participants (Anticipated)	Observational [Patient Registry]	2020-08-06	Recruiting
Comparison of Dobutamine Stress Echocardiography and Fractional Flow Reserve in Patients With Moderate Coronary Artery Disease: Stable and Non-culprit Lesions Investigation[NCT03383718]		200 participants (Actual)	Observational	2014-12-01	Completed
A Developmental Clinical Study of Management Guided by Coronary Angiography Combined With Fractional Flow Reserve (FFR) Measurement Versus Management Guided by Coronary Angiography Alone(Standard Care) in Patients With Non-ST Elevation MI.[NCT01764334]	Phase 4	350 participants (Actual)	Interventional	2011-10-31	Active, not recruiting
SEA-SIDE: Sirolimus Versus Everolimus-eluting Stent Randomized Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis[NCT00697372]	Phase 4	150 participants (Actual)	Interventional	2007-09-30	Completed
Prospective Randomized Study of the Paclitaxel-Coated Balloon Catheter in Bifurcated Coronary Lesions / BABILON Study (Paclitaxel-Coated Balloon in Bifurcated Lesions)[NCT01278186]	Phase 4	190 participants (Anticipated)	Interventional	2010-06-30	Active, not recruiting
Prospective, Randomized, Single-Center Evaluation of the Cypher™ Sirolimus Eluting Coronary Stent System in the Treatment of Bifurcated Coronary Lesions[NCT00288535]	Phase 4	200 participants (Anticipated)	Interventional	2005-03-31	Recruiting
Study of Lipid Core Plaque Shift at Sites of Native Coronary Artery Bifurcation[NCT00905671]	Phase 4	20 participants (Actual)	Interventional	2009-06-30	Completed
Z-SEA-SIDE: Sirolimus Versus Everolimus Versus Zotarolimus-eluting Stent Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis[NCT01200693]	Phase 4	80 participants (Actual)	Interventional	2008-11-30	Completed
Approaches to Chronic Occlusions With Sirolimus Stents-Cypher (ACROSS-Cypher) Total Occlusion Study of Coronary Arteries 4 Trial[NCT00378612]	Phase 3	200 participants (Actual)	Interventional	2005-06-30	Completed
ABILITY Diabetes Global[NCT04236609]		3,050 participants (Actual)	Interventional	2020-06-15	Active, not recruiting
Spot Drug-Eluting vs Full Cover Stenting for Long Coronary Stenoses: a Randomized Clinical Study[NCT00738556]		179 participants (Actual)	Interventional	2003-01-31	Completed
Ongoing WARfarin and Coronary STENTing. A Multi-center, Prospective Registry on Antithrombotic Treatment.[NCT00722319]		1,000 participants (Anticipated)	Observational	2009-03-31	Active, not recruiting
Prospective, Single-Arm, Multi-Centre, Observational Registry to Further Validate Safety and Efficacy of the Nobori DES in Real-World Patients[NCT01261273]		18,000 participants (Actual)	Observational	2010-08-25	Completed
BIOTRONIK-Safety and Clinical PerFormance of the Drug ELuting Orsiro Stent in the Treatment of Subjects With de Novo Coronary Artery Lesions-VI[NCT02870985]	Phase 3	440 participants (Anticipated)	Interventional	2015-07-31	Recruiting
Comparison of Platelet Inhibitory Effect With Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction Patients According to CYP2C19 Polymorphism[NCT00915733]	Phase 4	80 participants (Actual)	Interventional	2009-05-31	Completed
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial[NCT00991029]	Phase 3	4,881 participants (Actual)	Interventional	2010-05-28	Terminated (stopped due to The trial was halted by the DSMB.)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

"BARC definition. We only considered BARC 3 or 5 for this secondary safety endpoint.~Type 3: Clinical, laboratory, and/or imaging evidence of bleeding with:~Type 3a:~Overt bleeding + Hb drop of 3 to < 5 g/dL (provided Hb drop is related to bleed)~Any transfusion with overt bleeding~Type 3b:~Overt bleeding + Hb drop ≥5 g/dL (provided Hb drop is related to bleed)~Cardiac tamponade~Bleeding requiring surgical intervention (excluding dental/nasal/skin/haemorrhoid)~Bleeding requiring intravenous vasoactive agents~Type 3c:~Intracranial haemorrhage (does not include microbleeds or haemorrhagic transformation, does include intraspinal)~Subcategories confirmed by autopsy or imaging or lumbar puncture~Intraocular bleed compromising vision. Type 5: Fatal bleeding~Type 5a:~• Probable fatal bleeding; no autopsy or imaging confirmation but clinically suspicious~Type 5b:~Definite fatal bleeding; overt bleeding or autopsy or imaging confirmation" (NCT01813435)
Timeframe: 2 year

Number of Participants With a Composite of All-cause Mortality or Non-fatal New Q-wave Myocardial Infarction (MI)

Intervention	Participants (Count of Participants)
Experimental Treatment Strategy	163
Reference Treatment Strategy	169

Number of Participants with a composite of all-cause mortality or non-fatal new Q-wave MI up to 2 years post randomisation. (NCT01813435)
Timeframe: 2 year

Number of Participants With a Composite of All-cause Mortality, Stroke, or New Q-wave Myocardial Infarction

Intervention	Participants (Count of Participants)
Experimental Treatment Strategy	304
Reference Treatment Strategy	349

shown are the first event per event type for each patient only. Multiple events of the same type within the same patient are disregarded (NCT01813435)
Timeframe: 2-year

Number of Participants With a Definite Stent Thrombosis

Number of Participants With a Myocardial Revascularisation

Number of Participants With a Stroke

Number of Participants With All-cause Mortality

Number of Participants With Myocardial Infarction

Number of Participants With New Q-wave Myocardial Infarction

Multiplate ADP Test

Intervention	Participants (Count of Participants)
Experimental Treatment Strategy	362
Reference Treatment Strategy	416

Intervention	Participants (Count of Participants)
Experimental Treatment Strategy	64
Reference Treatment Strategy	64

Intervention	Participants (Count of Participants)
Experimental Treatment Strategy	739
Reference Treatment Strategy	793

Intervention	Participants (Count of Participants)
Experimental Treatment Strategy	80
Reference Treatment Strategy	82

Intervention	Participants (Count of Participants)
Experimental Treatment Strategy	224
Reference Treatment Strategy	253

Intervention	Participants (Count of Participants)
Experimental Treatment Strategy	248
Reference Treatment Strategy	250

Intervention	Participants (Count of Participants)
Experimental Treatment Strategy	83
Reference Treatment Strategy	103

"Platelet activation by adenosine diphosphate (ADP) expressed in arbitrary aggregation units (U). P2Y12 inhibitors block ADP receptors and decrease platelet activation by ADP. Higher values mean less effect of P2Y12 inhibitors, lower values mean more effect of P2Y12 inhibitors on platelets.~High on-treatment platelet reactivity was defined as >46 U." (NCT02224274)
Timeframe: 12 hours after P2Y12 inhibitor loading

VerifyNow P2Y12Test - % Inhibition

Intervention	U (Mean)
Clopidogrel	28
Ticagrelor	15

% inhibition reflects P2Y12 inhibitor effect regarding basal platelet reactivity (defined as: (1- (platelet reactivity/basal platelet reactivity)) x 100). Higher values mean better P2Y12 inhibition response. High on-treatment platelet reactivity was defined as <11% inhibition. (NCT02224274)
Timeframe: 12 hours after P2Y12 inhibitor loading

VerifyNow P2Y12Test - Platelet Reactivity

Intervention	% inhibition (Mean)
Clopidogrel	4
Ticagrelor	55

Platelet reactivity reflects P2Y12 inhibitor effect. Higher values mean normal platelet reactivity due to low P2Y12 inhibition response, while lower values mean decreased platelet reactivity due to the effect of a P2Y12 inhibitor. High on-treatment platelet reactivity was defined as >208 PRU. (NCT02224274)
Timeframe: 12 h after P2Y12 inhibitor loading

Incidence of Major Adverse Coronary Events Within One Year Following Surgery

Incidence of Major Bleeding Events Within One Year Following Surgery

Vein Graft Angiographic Patency

Intervention	PRU (Mean)
Clopidogrel	238
Ticagrelor	101

Intervention	Participants (Count of Participants)
75mg Clopidogrel	4
Placebo	5

Intervention	Participants (Count of Participants)
75mg Clopidogrel	1
Placebo	0

Postoperative angiogram 12 months post-CABG (NCT00228423)
Timeframe: One year following surgery

Vein Graft Intimal Area

Intervention	percentage (Number)
75mg Clopidogrel	94.3
Placebo	93.2

IVUS imaging 12 months post-CABG, and the average intimal area in the proximal 40 mm of one vein graft per patient will be assessed (NCT00228423)
Timeframe: One year following surgery

Major Adverse Cardiac Event Rate (MACE)

Intervention	mm (Mean)
75mg Clopidogrel	4.1
Placebo	4.5

MACE: A composite of all cause death, documented MI, unplanned hospitalization leading to urgent revascularization. (NCT01132495)
Timeframe: 24 Month

Overall MACE

Intervention	percentage of subjects with SAEs (Number)
	Non Urgent Revascularization	Death or Myocardial Infarction	Myocardial Infarction	Unplanned Hospitalizations with urgent revasc	Death	Cerebrovascular Event	Other Serious Adverse Event (SAE)
Cohort A - OMT Alone	32.7	12.2	9.3	13.4	3.9	1.4	0.7
Cohort A - PCI Plus OMT	6.7	9.4	6.7	1.8	3.6	2.2	0.2

Individual components of the primary end point, cardiac death, and nonurgent revascularization (NCT01132495)
Timeframe: 3 years

Composite of Ischemic Stroke, Myocardial Infarction, Death From Ischemic Vascular Causes, or Major Hemorrhage

Intervention	percentage of subjects (Number)
	Overall MACE	Death from any cause	Myocardial infarction	Urgent revascularization	Any revascularization	Nonurgent revascularization	Cardiac death
Cohort A: OMT Alone	22	3.6	7.7	17.2	44.2	30.2	1.1
Cohort A: PCI Plus OMT	10.1	2.7	6.3	4.3	10.3	6.3	1.1
Cohort B: Registry Cohort	12.7	3.0	6.6	6.6	14.5	9.0	1.8

Secondary efficacy outcome: Number of participants with ischemic stroke, myocardial infarction, death from ischemic vascular causes, or major hemorrhage (NCT00991029)
Timeframe: Up to 90 days

Composite of Ischemic Stroke, Myocardial Infarction, or Death From Ischemic Vascular Causes

Intervention	Participants (Count of Participants)
Clopidogrel	141
Placebo	167

Primary efficacy outcome: Number of Participants with Ischemic Stroke, Myocardial Infarction, or Death From Ischemic Vascular Causes (NCT00991029)
Timeframe: Up to 90 days

Death From Any Cause

Intervention	Participants (Count of Participants)
Clopidogrel	121
Placebo	160

Other safety outcome: Number of Participants with Death from any cause (NCT00991029)
Timeframe: up to 90 days

Death From Ischemic Vascular Causes

Intervention	Participants (Count of Participants)
Clopidogrel	18
Placebo	12

Secondary efficacy outcome: Number of participants with Death from ischemic vascular causes (NCT00991029)
Timeframe: Up to 90 days

Hemorrhagic Stroke

Intervention	Participants (Count of Participants)
Clopidogrel	6
Placebo	4

Other safety outcome: Number of participants with Hemorrhagic stroke (NCT00991029)
Timeframe: up to 90 days

Ischemic or Hemorrhagic Stroke

Intervention	Participants (Count of Participants)
Clopidogrel	5
Placebo	3

Secondary efficacy outcome: Number of participants with Ischemic or hemorrhagic stroke (NCT00991029)
Timeframe: Up to 90 days

Ischemic Stroke

Intervention	Participants (Count of Participants)
Clopidogrel	116
Placebo	156

Secondary efficacy outcome:Number of participants with Ischemic stroke (NCT00991029)
Timeframe: Up to 90 days

Major Hemorrhage

Intervention	Participants (Count of Participants)
Clopidogrel	112
Placebo	155

Primary safety outcome: Number of Participants with major hemorrhage (NCT00991029)
Timeframe: Up to 90 days

Major Hemorrhage Other Than Intracranial Hemorrhage

Intervention	Participants (Count of Participants)
Clopidogrel	23
Placebo	10

Other safety outcome: Number of Participants with Major hemorrhage other than intracranial hemorrhage (NCT00991029)
Timeframe: up to 90 days

Minor Hemorrhage

Intervention	Participants (Count of Participants)
Clopidogrel	17
Placebo	7

Other safety outcome:Number of Participants with Minor hemorrhage (NCT00991029)
Timeframe: up to 90 days

Myocardial Infarction

Intervention	Participants (Count of Participants)
Clopidogrel	40
Placebo	13

Secondary efficacy outcome: Number of participants with Myocardial infarction (NCT00991029)
Timeframe: Up to 90 days

Other Symptomatic Intracranial Hemorrhage

Intervention	Participants (Count of Participants)
Clopidogrel	10
Placebo	7

Other safety outcome: Number of participants with other symptomatic intracranial hemorrhage (NCT00991029)
Timeframe: up to 90 days

Symptomatic Intracerebral Hemorrhage

Intervention	Participants (Count of Participants)
Clopidogrel	2
Placebo	0

Other safety outcome: Number of participants with Symptomatic intracerebral hemorrhage (NCT00991029)
Timeframe: up to 90 days

Article	Year
Risk stratification of non-obstructive coronary artery disease for guidance of preventive medical therapy. Atherosclerosis, 2019, Volume: 290 Topics: Aged; Aspirin; Clinical Decision-Making; Computed Tomography Angiography; Coronary Angiography; Coro	2019
Continuation of Dual Antiplatelet Therapy in a Patient with a Coronary Artery Stent with Dengue Hemorrhagic Fever: A Clinical Conundrum. The American journal of tropical medicine and hygiene, 2020, Volume: 102, Issue:1 Topics: Aspirin; Clopidogrel; Coronary Stenosis; Drug-Eluting Stents; Dual Anti-Platelet Therapy; Humans; Ma	2020
Anticoagulant and anti-thrombotic therapy in acute type B aortic dissection: when real-life scenarios face the shadows of the evidence-based medicine. BMC cardiovascular disorders, 2020, 01-23, Volume: 20, Issue:1 Topics: Anticoagulants; Aortic Aneurysm, Thoracic; Aortic Dissection; Aspirin; Clinical Decision-Making; Clo	2020
Effect of Rivaroxaban and Clopidogrel Combination Therapy on In-Stent Responses After Everolimus-Eluting Stent Implantation in a Porcine Coronary Model. Journal of atherosclerosis and thrombosis, 2022, Jan-01, Volume: 29, Issue:1 Topics: Animals; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Vessels; Drug Therapy, Combination; Drug-	2022
Sex Differences in Coronary Arterial Calcification in Symptomatic Patients. The American journal of cardiology, 2021, 06-15, Volume: 149 Topics: Adult; Aspirin; Chest Pain; Cohort Studies; Computed Tomography Angiography; Coronary Angiography; C	2021
Early endothelialization associated with a biolimus A9 bioresorbable polymer stent in a porcine coronary model. Heart and vessels, 2017, Volume: 32, Issue:10 Topics: Absorbable Implants; Animals; Aspirin; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; End	2017
Computed Tomography Angiography Images of Coronary Artery Stenosis Provide a Better Prediction of Risk Than Traditional Risk Factors in Asymptomatic Individuals With Type 2 Diabetes: A Long-term Study of Clinical Outcomes. Diabetes care, 2017, Volume: 40, Issue:9 Topics: Aged; Aspirin; Cholesterol; Computed Tomography Angiography; Coronary Angiography; Coronary Artery D	2017
Comparison of the 9-month intra-stent conditions and 2-year clinical outcomes after Resolute zotarolimus-eluting stent implantation between 3-month and standard dual antiplatelet therapy. Journal of cardiology, 2018, Volume: 72, Issue:1 Topics: Aged; Angina Pectoris; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Vessels; Drug Administratio	2018
Vessel wall enhancement by gadolinium-enhanced MRI in a patient with delayed stenosis after mechanical thrombectomy. BMJ case reports, 2018, Jul-26, Volume: 2018 Topics: Angiography, Digital Subtraction; Aspirin; Coronary Stenosis; Female; Gadolinium; Humans; Image Proc	2018
Impact of long-term therapy with acetylsalicylic acid on immature platelet count: a single-centre cohort study. Journal of cardiovascular medicine (Hagerstown, Md.), 2019, Volume: 20, Issue:5 Topics: Aged; Aspirin; Blood Platelets; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Cr	2019
Subacute bioresorbable vascular scaffold thrombosis: a report of 2 cases. Heart and vessels, 2015, Volume: 30, Issue:4 Topics: Absorbable Implants; Adenosine; Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Stenosis;	2015
Successful treatment of bleeding large duodenal gastrointestinal stromal tumour in a patient under dual antiplatelet therapy after recent drug-eluting coronary stent implantation. BMJ case reports, 2014, Apr-28, Volume: 2014 Topics: Aged; Aspirin; Benzamides; Chemotherapy, Adjuvant; Clopidogrel; Coronary Stenosis; Drug-Eluting Sten	2014
Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial. Circulation, 2014, Sep-09, Volume: 130, Issue:11 Suppl 1 Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; C	2014
Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial. Circulation, 2014, Sep-09, Volume: 130, Issue:11 Suppl 1 Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; C	2014
Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial. Circulation, 2014, Sep-09, Volume: 130, Issue:11 Suppl 1 Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; C	2014
Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial. Circulation, 2014, Sep-09, Volume: 130, Issue:11 Suppl 1 Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; C	2014
Prognostic and therapeutic implications of statin and aspirin therapy in individuals with nonobstructive coronary artery disease: results from the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter registry) re Arteriosclerosis, thrombosis, and vascular biology, 2015, Volume: 35, Issue:4 Topics: Adult; Aged; Asia; Aspirin; Canada; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis	2015
Endobronchial biopsies on aspirin and prasugrel. Heart, lung & circulation, 2015, Volume: 24, Issue:6 Topics: Angioplasty, Balloon, Coronary; Aspirin; Biopsy, Needle; Bronchoscopy; Carcinoma, Squamous Cell; Cor	2015
Accuracy of optical frequency domain imaging for evaluation of coronary adventitial vasa vasorum formation after stent implantation in pigs and humans - a validation study - . Circulation journal : official journal of the Japanese Circulation Society, 2015, Volume: 79, Issue:6 Topics: Adventitia; Aged; Aged, 80 and over; Animals; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Vess	2015
Two young women with severe coronary arterial ostial narrowing: A potential subtype of Takayasu arteritis. International journal of cardiology, 2015, Volume: 189 Topics: Adult; Aspirin; Clopidogrel; Coronary Angiography; Coronary Stenosis; Cyclophosphamide; Diagnosis, D	2015
Long-term Outcomes of Medical Therapy Versus Coronary Revascularisation in Patients with Intermediate Stenoses Guided by Pressure Wire. Annals of the Academy of Medicine, Singapore, 2015, Volume: 44, Issue:5 Topics: Adult; Aged; Aspirin; Clopidogrel; Coronary Stenosis; Drug Therapy, Combination; Female; Follow-Up S	2015
Kounis syndrome with Samter-Beer triad treated with intracoronary adrenaline. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2015, Nov-15, Volume: 86, Issue:6 Topics: Anaphylaxis; Aspirin; Asthma; Chest Pain; Coronary Stenosis; Coronary Vessels; Electrocardiography;	2015
Bridge therapy or standard treatment for urgent surgery after coronary stent implantation: Analysis of 314 patients. Vascular pharmacology, 2016, Volume: 80 Topics: Ambulatory Care; Aspirin; Blood Vessel Prosthesis Implantation; Coronary Stenosis; Humans; Platelet	2016
Clinical implications of low-dose aspirin on vasospastic angina patients without significant coronary artery stenosis; a propensity score-matched analysis. International journal of cardiology, 2016, Oct-15, Volume: 221 Topics: Angina Pectoris, Variant; Aspirin; Coronary Angiography; Coronary Stenosis; Coronary Vasospasm; Coro	2016
A randomized clinical trial comparing long-term clopidogrel vs aspirin monotherapy beyond dual antiplatelet therapy after drug-eluting coronary stent implantation: Design and rationale of the Harmonizing Optimal Strategy for Treatment of coronary artery s American heart journal, 2017, Volume: 185 Topics: Acute Coronary Syndrome; Aspirin; Cause of Death; Clopidogrel; Coronary Stenosis; Drug Therapy, Comb	2017
Reversible clopidogrel resistance due to right ventricular myocardial infarction: risk factor of recurrent stent thrombosis? Clinical research in cardiology : official journal of the German Cardiac Society, 2008, Volume: 97, Issue:11 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug R	2008
Association between the efficacy of dual antiplatelet therapy and the development of in-stent neointimal hyperplasia in porcine coronary arteries. Coronary artery disease, 2008, Volume: 19, Issue:8 Topics: Adenosine Diphosphate; Angioplasty, Balloon, Coronary; Animals; Aspirin; Cell Proliferation; Clopido	2008
Death caused by simultaneous subacute stent thrombosis of sirolimus-eluting stents in left anterior descending artery and left circumflex artery. International journal of cardiology, 2010, Apr-01, Volume: 140, Issue:1 Topics: Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Occ	2010
Risk stratification after coronary artery bypass surgery by a point-of-care test of platelet function. The Annals of thoracic surgery, 2009, Volume: 87, Issue:2 Topics: Aged; Aspirin; Cohort Studies; Coronary Artery Bypass; Coronary Stenosis; Dose-Response Relationship	2009
Invited commentary. The Annals of thoracic surgery, 2009, Volume: 87, Issue:2 Topics: Aspirin; Coronary Stenosis; Humans; Platelet Aggregation; Platelet Function Tests; Point-of-Care Sys	2009
Athero-embolic isolated splenic infarction following left cardiac catheterization. Journal of cardiovascular medicine (Hagerstown, Md.), 2009, Volume: 10, Issue:3 Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aortic Aneurysm, Abdominal; Aspirin; Atherosclerosis	2009
Spontaneous spinal epidural hematoma: an urgent complication of adding clopidogrel to aspirin therapy. Journal of the neurological sciences, 2009, Oct-15, Volume: 285, Issue:1-2 Topics: Aspirin; Clopidogrel; Coronary Stenosis; Decompression, Surgical; Drug Interactions; Hematoma, Epidu	2009
Impact of coronary computed tomographic angiography findings on the medical treatment and control of coronary artery disease and its risk factors. The American journal of cardiology, 2009, Oct-01, Volume: 104, Issue:7 Topics: Adult; Aged; Ambulatory Care; Antihypertensive Agents; Aspirin; Cholesterol, LDL; Cohort Studies; Co	2009
Changes in platelets and anticoagulant protein activity during adenosine-exercise single-photon emission computed tomography stress test. Srpski arhiv za celokupno lekarstvo, 2010, Volume: 138 Suppl 1 Topics: Adenosine; Adenosine Diphosphate; Adult; Aged; Antithrombins; Aspirin; beta-Thromboglobulin; Blood C	2010
Defining patients at high risk for gastrointestinal hemorrhage after drug-eluting stent placement: a cost utility analysis. Journal of interventional cardiology, 2010, Volume: 23, Issue:2 Topics: Angioplasty, Balloon, Coronary; Aspirin; Cohort Studies; Coronary Stenosis; Cost-Benefit Analysis; D	2010
Intracoronary shear-related up-regulation of platelet P-selectin and platelet-monocyte aggregation despite the use of aspirin and clopidogrel. Blood, 2011, Jan-06, Volume: 117, Issue:1 Topics: Aged; Aspirin; Blood Platelets; CD11b Antigen; Clopidogrel; Coronary Artery Disease; Coronary Stenos	2011
Three-month dual antiplatelet therapy after implantation of zotarolimus-eluting stents: the DATE (Duration of Dual Antiplatelet Therapy AfterImplantation of Endeavor Stent) registry. Circulation journal : official journal of the Japanese Circulation Society, 2010, Volume: 74, Issue:11 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Agents; Chi-Square Distribution; Clopi	2010
Clinical and angiographic outcomes with sirolimus-eluting stent for coronary bifurcation lesions. The J-PMS study. Circulation journal : official journal of the Japanese Circulation Society, 2011, Volume: 75, Issue:2 Topics: Angioplasty; Aspirin; Calcinosis; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coro	2011
Feasibility and safety of 7-Fr radial approach for complex PCI. Journal of interventional cardiology, 2011, Volume: 24, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Arter	2011
Fabry disease and Factor V Leiden: a potent vascular risk combination. Internal medicine journal, 2011, Volume: 41, Issue:5 Topics: Activated Protein C Resistance; alpha-Galactosidase; Aspirin; Atorvastatin; Coronary Stenosis; Defib	2011
A complex case of angulated and bifurcated lesion facilitated by excimer laser coronary angioplasty. Journal of interventional cardiology, 2011, Volume: 24, Issue:6 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Stenosis; Hu	2011
Hospital variability in the rate of finding obstructive coronary artery disease at elective, diagnostic coronary angiography. Journal of the American College of Cardiology, 2011, Aug-16, Volume: 58, Issue:8 Topics: Adrenergic beta-Antagonists; Age Distribution; Aspirin; Coronary Angiography; Coronary Artery Diseas	2011
Aborted myocardial infarction in a patient with rapid progression of Wellens syndrome. The Journal of emergency medicine, 2012, Volume: 43, Issue:3 Topics: Aspirin; Clopidogrel; Coronary Stenosis; Early Diagnosis; Electrocardiography; Humans; Male; Middle	2012
Gene therapy with iNOS enhances regional contractility and reduces delayed contrast enhancement in a model of postischemic congestive heart failure. Clinical hemorheology and microcirculation, 2011, Volume: 49, Issue:1-4 Topics: Animals; Anticoagulants; Aspirin; Clopidogrel; Contrast Media; Coronary Angiography; Coronary Stenos	2011
Bead-like coronary spasm. Internal medicine journal, 2012, Volume: 42, Issue:3 Topics: Aspirin; Bradycardia; Calcium Channel Blockers; Chest Pain; Coronary Angiography; Coronary Stenosis;	2012
Simultaneous subacute thrombosis of bare metal coronary stents in two different arteries early after clopidogrel cessation. Cardiology journal, 2012, Volume: 19, Issue:3 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Stenosis; Coron	2012
Long-term successful percutaneous coronary intervention in factor VII deficiency. The Journal of invasive cardiology, 2012, Volume: 24, Issue:6 Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Diabetes M	2012
Dual antiplatelet therapy after drug-eluting stent implantation: is it time to slacken the reins? Journal of the American College of Cardiology, 2012, Oct-09, Volume: 60, Issue:15 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Stenosis; Dr	2012
Deliverability of integrity coronary stents in severely tortuous coronary arteries: a preliminary experience. The Journal of invasive cardiology, 2012, Volume: 24, Issue:12 Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Female; Human	2012
Unclassified pleomorphic and spindle cell pulmonary neoplasm with brain metastases after prasugrel. Cardiology, 2013, Volume: 124, Issue:2 Topics: Aged; Aspirin; Brain Neoplasms; Carcinoma; Clinical Trials, Phase III as Topic; Clopidogrel; Colonic	2013
Coronary artery spasm associated with a moderately severe atherosclerotic stenosis in the proximal LAD. The Journal of invasive cardiology, 2002, Volume: 14, Issue:12 Topics: Adult; Aspirin; Atorvastatin; Cardiac Catheterization; Coronary Angiography; Coronary Artery Disease	2002
[Off-label use of clopidogrel after coronary stent implantation in Germany: optional or mandatory?]. Herz, 2003, Volume: 28, Issue:1 Topics: Aspirin; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Drug Approval; Drug Costs; Drug Prescr	2003
Long-term prognosis of patients with acute coronary syndrome and moderate coronary artery stenosis. Cardiology, 2003, Volume: 99, Issue:2 Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Angina, Unstable; Aspirin; Coronary Angiography; C	2003
Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2003, Volume: 59, Issue:3 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Case-Control Studies; Cell Adhesio	2003
Clopidogrel is associated with better in-hospital and 30-day outcomes than ticlopidine after coronary stenting. The Canadian journal of cardiology, 2003, Volume: 19, Issue:9 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cause of Death; Clopidogrel; Coronary Stenosis; Dose-	2003
Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation. Circulation, 2004, Feb-24, Volume: 109, Issue:7 Topics: Aged; Aspirin; Atherectomy, Coronary; Catheterization; Cilostazol; Combined Modality Therapy; Corona	2004
Percutaneous coronary intervention in a patient with immune thrombocytopenia purpura. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2004, Volume: 61, Issue:3 Topics: Aged; Angioplasty, Balloon; Aspirin; Clopidogrel; Coronary Angiography; Coronary Stenosis; Eptifibat	2004
Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. Circulation, 2004, Apr-13, Volume: 109, Issue:14 Topics: Aged; Angina Pectoris; Anticoagulants; Aspirin; Biomarkers; Blood Proteins; C-Reactive Protein; Coro	2004
Resistance to antiplatelet drugs: is it real or relevant? Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2004, Volume: 62, Issue:1 Topics: Angioplasty, Balloon, Coronary; Aspirin; Blood Vessel Prosthesis Implantation; Brachytherapy; Clopid	2004
Late stent thrombosis (> 1 year) following clopidogrel withdrawal after brachytherapy treatment: need to assess aspirin resistance? Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2004, Volume: 62, Issue:1 Topics: Adult; Angioplasty, Balloon, Coronary; Aspirin; Blood Vessel Prosthesis Implantation; Brachytherapy;	2004
Multivessel distal sutureless off-pump coronary artery bypass grafting procedure using magnetic connectors. The Annals of thoracic surgery, 2004, Volume: 78, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Bypass, Off-Pump; Corona	2004
National survey of coronary artery bypass grafting for coronary stenosis caused by Kawasaki disease in Japan. Circulation, 2004, Sep-14, Volume: 110, Issue:11 Suppl 1 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Angioplasty, Balloon, Coronary; Aspirin; Ch	2004
[How does it work? Coronary stent implantation]. MMW Fortschritte der Medizin, 2004, Jun-03, Volume: 146, Issue:23 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Drug T	2004
Off-pump coronary artery bypass grafting in a patient with congenital factor V deficiency: report of a case. Surgery today, 2005, Volume: 35, Issue:2 Topics: Aspirin; Blood Coagulation Factors; Blood Component Transfusion; Blood Loss, Surgical; Coronary Arte	2005
Long-term changes in coronary artery aneurysms in patients with Kawasaki disease: comparison of therapeutic regimens. Circulation journal : official journal of the Japanese Circulation Society, 2005, Volume: 69, Issue:3 Topics: Acute Disease; Aspirin; Coronary Aneurysm; Coronary Stenosis; gamma-Globulins; Humans; Longitudinal	2005
Dual antiplatelet therapy for coronary stenting: a clear path for a research agenda. Circulation, 2005, Mar-08, Volume: 111, Issue:9 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug A	2005
Very late thrombosis after implantation of sirolimus eluting stent. Heart (British Cardiac Society), 2005, Volume: 91, Issue:6 Topics: Adult; Aspirin; Blood Vessel Prosthesis; Catheterization; Clopidogrel; Coronary Angiography; Coronar	2005
The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosis. American heart journal, 2005, Volume: 149, Issue:4 Topics: Aged; Alleles; Antigens, Human Platelet; Aspirin; Coronary Restenosis; Coronary Stenosis; DNA Mutati	2005
Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting. American heart journal, 2005, Volume: 150, Issue:2 Topics: Abciximab; Aged; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Mono	2005
Borderline coronary lesions may lead to serious coronary events--long-term outcome in 65 conservatively treated patients. Kardiologia polska, 2005, Volume: 63, Issue:7 Topics: Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cardiovascular Agents; Coronary	2005
Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry. Circulation, 2006, Mar-21, Volume: 113, Issue:11 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cause of Death; Clopidogrel; Comorbidity; Coronary Di	2006
Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry. Circulation, 2006, Mar-21, Volume: 113, Issue:11 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cause of Death; Clopidogrel; Comorbidity; Coronary Di	2006
Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry. Circulation, 2006, Mar-21, Volume: 113, Issue:11 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cause of Death; Clopidogrel; Comorbidity; Coronary Di	2006
Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry. Circulation, 2006, Mar-21, Volume: 113, Issue:11 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cause of Death; Clopidogrel; Comorbidity; Coronary Di	2006
Combined aspirin and clopidogrel resistance associated with recurrent coronary stent thrombosis. Clinical research in cardiology : official journal of the German Cardiac Society, 2006, Volume: 95, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Rest	2006
Rebound platelet activation after termination of prasugrel and aspirin therapy due to confirmed non-compliance in patient enrolled in the JUMBO Trial. International journal of clinical practice, 2006, Volume: 60, Issue:7 Topics: Angina Pectoris; Aspirin; Chronic Disease; Coronary Stenosis; Drug Therapy, Combination; Humans; Mal	2006
Long-term clinical outcome of patients treated with beta-brachytherapy in routine clinical practice. International journal of cardiology, 2007, Feb-07, Volume: 115, Issue:2 Topics: Aspirin; Brachytherapy; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Female; Follow-Up Studi	2007
Cyclooxygenase-2 inhibitors enhance shear stress-induced platelet aggregation. Journal of the American College of Cardiology, 2006, Aug-15, Volume: 48, Issue:4 Topics: Animals; Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Stenosis; Cyclooxygenase Inhibitors;	2006
Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events. The American journal of cardiology, 2006, Nov-01, Volume: 98, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Coronary Stenosis; Disease-	2006
Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline. Chest, 2006, Volume: 130, Issue:6 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillatio	2006
Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry. Circulation, 2007, Jun-26, Volume: 115, Issue:25 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Angi	2007
The influence of low (81 mg) versus high (325 mg) doses of ASA on the incidence of sirolimus-eluting stent thrombosis. The Journal of invasive cardiology, 2007, Volume: 19, Issue:7 Topics: Administration, Oral; Aged; Angioplasty, Balloon, Coronary; Aspirin; Coated Materials, Biocompatible	2007
Case report on clopidogrel rash after coronary placement of a paclitaxol-coated stent. Critical pathways in cardiology, 2007, Volume: 6, Issue:1 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Disease Progression; Drug H	2007
The truth and consequences of the COURAGE trial. Journal of the American College of Cardiology, 2007, Oct-16, Volume: 50, Issue:16 Topics: Adrenergic beta-Antagonists; Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Coronary Ang	2007
Coronary artery in-stent stenosis persists despite inhibition of the von Willebrand factor--collagen interaction in baboons. Thrombosis and haemostasis, 2007, Volume: 98, Issue:6 Topics: Angioplasty, Balloon, Coronary; Animals; Antibodies, Monoclonal; Aspirin; Clopidogrel; Collagen; Cor	2007
2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2008, Jan-01, Volume: 71, Issue:1 Topics: Acute Coronary Syndrome; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin;	2008
Comparison of a polymer-free rapamycin-eluting stent (YUKON) with a polymer-based paclitaxel-eluting stent (TAXUS) in real-world coronary artery lesions. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2008, Feb-15, Volume: 71, Issue:3 Topics: Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors	2008
Community-based provision of statin and aspirin after the detection of coronary artery calcium within a community-based screening cohort. Journal of the American College of Cardiology, 2008, Apr-08, Volume: 51, Issue:14 Topics: Adult; Aspirin; Calcinosis; Coronary Stenosis; Coronary Vessels; Fibrinolytic Agents; Follow-Up Stud	2008
Statins do not adversely affect post-interventional residual platelet aggregation and outcomes in patients undergoing coronary stenting treated by dual antiplatelet therapy. European heart journal, 2008, Volume: 29, Issue:13 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Coronary Stenosis; Cytochrome P-450 CYP3A; Dru	2008
Coronary revascularization and aggressive lipid lowering. The Journal of invasive cardiology, 1999, Volume: 11, Issue:2 Topics: Aspirin; Atorvastatin; Coronary Stenosis; Heptanoic Acids; Humans; Hyperlipidemias; Hypertension; Hy	1999
Edge stenosis after intracoronary radiotherapy: angiographic, intravascular, and histological findings. Circulation, 2001, May-01, Volume: 103, Issue:17 Topics: Aged; Angioplasty, Balloon, Laser-Assisted; Anticoagulants; Aspirin; Brachytherapy; Clopidogrel; Com	2001
Coronary stent thrombosis: insights from the porcine coronary stent model. Thrombosis and haemostasis, 2001, Volume: 86, Issue:3 Topics: Animals; Anticoagulants; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Coronary Vess	2001
Oral anticoagulation therapy during and after coronary angioplasty. Circulation, 2001, Dec-11, Volume: 104, Issue:24 Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Stenosis; Co	2001
Thrombostatin inhibits cyclic flow variations in stenosed canine coronary arteries. Thrombosis and haemostasis, 2001, Volume: 86, Issue:5 Topics: Animals; Aspirin; Blood Coagulation Tests; Bradykinin; Clopidogrel; Coronary Stenosis; Coronary Thro	2001

Article	Year
[2017 Update on dual antiplatelet therapy: what's new?] Giornale italiano di cardiologia (2006), 2018, Volume: 19, Issue:4 Topics: Advisory Committees; Aged; Aspirin; Coronary Angiography; Coronary Stenosis; Dose-Response Relations	2018
Diabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularization. Vascular health and risk management, 2009, Volume: 5, Issue:1 Topics: Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Agents; Clopidogrel; Coronary Angiography; C	2009
Efficacy of cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2009, Volume: 5, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Coronary Angiography; Coronary Restenosis	2009
Comparison of cilostazol and ticlopidine for one-month effectiveness and safety after elective coronary stenting. Cardiovascular drugs and therapy, 2004, Volume: 18, Issue:3 Topics: Administration, Oral; Aspirin; Cilostazol; Coronary Restenosis; Coronary Stenosis; Coronary Vessels;	2004
The role of platelet inhibition in the drug-eluting stent era. Coronary artery disease, 2004, Volume: 15, Issue:6 Topics: Aspirin; Coronary Stenosis; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-III	2004
Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004, Volume: 126, Issue:3 Suppl Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Clopidogrel; Contraindic	2004
Issues in the management of antiplatelet therapy in patients undergoing surgical revascularization. A roundtable discussion. The Journal of invasive cardiology, 2005, Volume: 17, Issue:5 Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Combined Modality Therapy; C	2005
Meta-analysis of trials comparing oral anticoagulation and aspirin versus dual antiplatelet therapy after coronary stenting. Clues for the management of patients with an indication for long-term anticoagulation undergoing coronary stenting. Cardiology, 2005, Volume: 104, Issue:2 Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary	2005
Current perspectives on Kawasaki disease. Indian journal of pediatrics, 2005, Volume: 72, Issue:7 Topics: Aspirin; Atherosclerosis; Coronary Aneurysm; Coronary Stenosis; Coronary Thrombosis; Female; Humans;	2005
[Triplex antithrombotic therapy after coronary-stent implantation (that is absent from recommendation)]. Orvosi hetilap, 2005, Sep-11, Volume: 146, Issue:37 Topics: Aspirin; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Coumarins; Drug Ther	2005
[Dual antithrombotic therapy after implantation of coronary stents]. Deutsche medizinische Wochenschrift (1946), 2006, May-12, Volume: 131, Issue:19 Topics: Aspirin; Clopidogrel; Coronary Stenosis; Dose-Response Relationship, Drug; Drug Synergism; Humans; P	2006
Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention. The American journal of cardiology, 2007, Oct-15, Volume: 100, Issue:8 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Drug Administration Schedul	2007

aspirin and Coronary Stenosis